Hjem › Multipelt myelom › Maine
Kliniske studier for Multipelt myelom i Maine
3 studier for Multipelt myelom søker deltakere på steder i Maine.
Offisiell studietekst (engelsk)
A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma
- Study Site 105, Westbrook
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07582432TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Harold Alfond Center for Cancer Care, Augusta
- Jackson Laboratory - Maine Cancer Genomics Initiative, Augusta
- Waldo County General Hospital, Belfast
- og 16 flere
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT02693535A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
- GSK Investigational Site, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. apr. 2026 · NCT06679101Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.